These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21431693)

  • 1. RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy.
    Liu YP; Westerink JT; ter Brake O; Berkhout B
    Methods Mol Biol; 2011; 721():293-311. PubMed ID: 21431693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral vector engineering for anti-HIV RNAi gene therapy.
    ter Brake O; Westerink JT; Berkhout B
    Methods Mol Biol; 2010; 614():201-13. PubMed ID: 20225046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
    Chang LJ; Liu X; He J
    Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1-specific RNA interference.
    Boden D; Pusch O; Ramratnam B
    Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
    ter Brake O; Konstantinova P; Ceylan M; Berkhout B
    Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
    ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
    Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
    ter Brake O; Berkhout B
    J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape.
    Leonard JN; Schaffer DV
    J Virol; 2005 Feb; 79(3):1645-54. PubMed ID: 15650190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction and in vitro antiviral activity of highly effective artificial miRNA targeting to HIV-1 pol].
    Cheng T; Zhang T; Zhang Y; Wei L; Xia D; Wang Y; Zhang J; Xia N
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):63-73. PubMed ID: 20353094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes.
    Li MJ; Rossi JJ
    Methods Enzymol; 2005; 392():218-26. PubMed ID: 15644184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of HIV-1 replication by RNA interference.
    Lee NS; Rossi JJ
    Virus Res; 2004 Jun; 102(1):53-8. PubMed ID: 15068880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
    Anderson J; Akkina R
    Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of HIV-1 gene expression by siRNAs in transduced cells.
    Hayafune M; Miyano-Kurosaki N; Takaku H; Park WS
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(7):795-9. PubMed ID: 16898417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of hairpin-based RNAi vectors for biological and therapeutic application.
    Boudreau RL; Davidson BL
    Methods Enzymol; 2012; 507():275-96. PubMed ID: 22365779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of multicopy shRNA lentiviral vectors for antiviral therapy.
    Henry SD; Pan Q; van der Laan LJ
    Methods Mol Biol; 2011; 721():313-32. PubMed ID: 21431694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a durable treatment of HIV-1 infection using RNA interference.
    Eekels JJ; Berkhout B
    Prog Mol Biol Transl Sci; 2011; 102():141-63. PubMed ID: 21846571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS.
    Akkina R; Banerjea A; Bai J; Anderson J; Li MJ; Rossi J
    Anticancer Res; 2003; 23(3A):1997-2005. PubMed ID: 12894572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.
    Chang LJ; Urlacher V; Iwakuma T; Cui Y; Zucali J
    Gene Ther; 1999 May; 6(5):715-28. PubMed ID: 10505094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
    Mautino MR; Morgan RA
    Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.